AdaptHealth Corp.
AHCO
$9.77
$0.161.67%
| Weiss Ratings | AHCO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | AHCO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AHCO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.23 | |||
| Price History | AHCO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -6.42% | |||
| 30-Day Total Return | -8.78% | |||
| 60-Day Total Return | 2.30% | |||
| 90-Day Total Return | -5.05% | |||
| Year to Date Total Return | 0.72% | |||
| 1-Year Total Return | -3.74% | |||
| 2-Year Total Return | -26.38% | |||
| 3-Year Total Return | -36.31% | |||
| 5-Year Total Return | -29.56% | |||
| 52-Week High % Change | -19.24% | |||
| 52-Week Low % Change | 15.09% | |||
| Price | AHCO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $11.90 | |||
| 52-Week Low Price | $8.35 | |||
| 52-Week Low Price (Date) | Feb 21, 2025 | |||
| 52-Week High Price (Date) | Jul 25, 2024 | |||
| Valuation | AHCO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.30B | |||
| Enterprise Value | 3.32B | |||
| Price/Earnings (TTM) | 16.08 | |||
| Earnings Per Share (TTM) | 0.60 | |||
| Earnings Per Share Growth | -111.25% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.40 | |||
| Price/Book (Q) | 0.81 | |||
| Enterprise Value/Revenue (TTM) | 1.02 | |||
| Price | $9.77 | |||
| Enterprise Value/EBITDA (TTM) | 4.95 | |||
| Enterprise Value/EBIT | 10.87 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | AHCO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 136.53M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AHCO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 610 424 4515 | |||
| Address | 220 West Germantown Pike Plymouth Meeting, PA 19462 | |||
| Website | adapthealth.com | |||
| Country | United States | |||
| Year Founded | 2012 | |||
| Profitability | AHCO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 9.36% | |||
| Profit Margin | 2.77% | |||
| Management Effectiveness | AHCO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 4.25% | |||
| Return on Equity | 6.23% | |||
| Income Statement | AHCO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 3.26B | |||
| Total Revenue (TTM) | 3.26B | |||
| Revenue Per Share | $23.88 | |||
| Gross Profit (TTM) | 749.16M | |||
| EBITDA (TTM) | 670.84M | |||
| EBIT (TTM) | 305.51M | |||
| Net Income (TTM) | 90.42M | |||
| Net Income Avl. to Common (TTM) | 90.42M | |||
| Total Revenue Growth (Q YOY) | -0.19% | |||
| Earnings Growth (Q YOY) | 120.27% | |||
| EPS Diluted (TTM) | 0.60 | |||
| EPS Diluted Growth (Q YOY) | 117.47% | |||
| Balance Sheet | AHCO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 112.65M | |||
| Cash Per Share (Q) | $0.83 | |||
| Total Current Assets (Q) | 755.79M | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | 1.58B | |||
| Current Ratio (Q) | 1.333 | |||
| Book Value Per Share (Q) | $11.93 | |||
| Total Assets (Q) | 4.49B | |||
| Total Current Liabilities (Q) | 566.99M | |||
| Total Debt (Q) | 2.13B | |||
| Total Liabilities (Q) | 2.91B | |||
| Total Common Equity (Q) | 1.57B | |||
| Cash Flow | AHCO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -310.28M | |||
| Cash from Financing (TTM) | -198.95M | |||
| Net Change in Cash (TTM) | 32.62M | |||
| Levered Free Cash Flow (TTM) | 177.22M | |||
| Cash from Operations (TTM) | 541.84M | |||
